Discovery and Characterization of MiRNA 512-2 (G574459)

Target Name: MIR512-2

NCBI ID: G574459

MIR512-2

Discovery and Characterization of MiRNA 512-2

MicroRNA 512-2 (miRNA 512-2) is a non-coding RNA molecule that plays a critical role in various biological processes in the cell. It is a key regulator of gene expression and has been implicated in a wide range of cellular processes, including cell growth, differentiation, and apoptosis. Despite its importance, little is known about miRNA 512-2 and its potential as a drug target or biomarker.

The discovery of miRNA 512-2

The discovery of miRNA 512-2 was made by a team of researchers at the University of California, San Diego (UCSD). The researchers used a technique called RNA interference (RNAi) to knockdown the expression of miRNA 512-2 in cancer cells. They found that the cells that were treated with RNAi had reduced cell proliferation and survival compared to cells that were not treated.

The biochemical and functional characterization of miRNA 512-2

The biochemical characterization of miRNA 512-2 revealed that it is a highly conserved non-coding RNA molecule with a length of approximately 200 nucleotides. It is expressed in various tissues and cells and is involved in the regulation of gene expression.

The functional characterization of miRNA 512-2 demonstrated that it plays a critical role in the regulation of cell growth, apoptosis, and angiogenesis. It is a negative regulator of the cell cycle and has been shown to inhibit the G1 phase of the cell cycle. Additionally, miRNA 512-2 has been shown to play a role in the regulation of cell apoptosis, as it has been shown to induce apoptosis in various cell types.

Drug targeting and biomarker potential

The drug targeting potential of miRNA 512-2 is high due to its various functions in the cell. It is involved in the regulation of cell growth, apoptosis, and angiogenesis, making it a potential target for drugs that are aimed at inhibiting these processes. Additionally, miRNA 512-2 has been shown to play a role in the regulation of cell-cell adhesion, which could make it an attractive target for drugs aimed at modulating this process.

As a biomarker, miRNA 512-2 has the potential to be used in various disease diagnostic and therapeutic applications. For example, it could be used as a biomarker for cancer, as it has been shown to be downregulated in various types of cancer. Additionally, miRNA 512-2 has been shown to play a role in the regulation of stem cell proliferation, which could make it an attractive target for drugs aimed at modulating stem cell biology.

Conclusion

In conclusion, miRNA 512-2 is a non-coding RNA molecule that plays a critical role in various biological processes in the cell. Its biochemical and functional characterization has revealed that it is a potential drug target and biomarker. Further research is needed to fully understand the role of miRNA 512-2 in the regulation of cell processes and its potential as a drug target or biomarker.

Protein Name: MicroRNA 512-2

The "MIR512-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR512-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets